Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZYNRELEF vs Standard of Care for Pain Management Following Total Knee Arthroplasty
NCT05644496Phase 4Terminated
- Sponsor
- Baptist Health South Florida
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Baptist Health South Florida. Started Mar 2023; status: terminated.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05644496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05644496.